IP Library Granted Patent US 12,188,054
Granted Patent B2
US 12,188,054 · App. 17/607,918 · Granted Jan 7, 2025

Modified monooxygenases for the manufacture of hydroxylated hydrocarbons based on substitution of amino acids by alanine

Inventors: Ruijing Guo (Shanghai, CN); Jen-Chieh Lin (Singapur, SG); Sha Tao (Nanjing, CN); Ying Qian (Nanjing, CN); Chenggang Qiu (Nanjing, CN); Kequan Chen (Nanjing, CN); Kang Li (Nanjing, CN)
Assignee: Covestro Deutschland AG
C12N9/0077C12N9/0079C12N15/00C12P7/22C12P17/06C12Y114/15004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,188,054
App. No.
17/607,918
Granted
Jan 7, 2025
Kind
B2
Abstract

The present invention relates to novel monooxygenases which are useful in the hydroxylation of aromatic hydrocarbons. They are particularly useful for the production of 1-naththol and 7-hydroxycoumarin from naphthol and 7-Ethoxycoumarin, respectively.

Claims (27)

1. A modified P450 monooxygenase having an amino acid sequence with at least 95% sequence identity with SEQ ID NO.: 1, wherein at least one amino acid of SEQ ID NO.: 1 selected from the group consisting of leucine 87, glutamic acid 88, lysine 89, isoleucine 90, threonine 91, proline 92, valine 93, serine 94, glutamic acid 96, threonine 98, threonine 100, leucine 101, arginine 103, tyrosine 104, aspartic acid 105, histidine 196, threonine 197, valine 198, asparagine 199, threonine 200, tryptophan 201, glycine 202, arginine 203, proline 204, proline 206, glutamic acid 207, glutamic acid 208, glutamine 209, valine 210, and combinations thereof is substituted by alanine, leading to an improved reactivity on hydroxylation of aromatic hydrocarbons as compared to a non-modified P450 oxygenase.

2. The modified P450 monooxygenase according to claim 1 , wherein glutamine at position 209 is substituted by alanine.

3. The modified P450 monooxygenase according to claim 2 , further comprising at least one of the following substitutions:

a) substitution of glutamic acid at position 88 by an amino acid selected from the group consisting of alanine, serine, histidine, threonine, cysteine, methionine, and asparagine; and/or

b) substitution of asparagine at position 199 by an amino acid selected from the group consisting of glutamine, isoleucine, leucine, phenylalanine, histidine, methionine, arginine, serine, threonine, tyrosine, tryptophan, alanine, valine, and lysine.

4. The modified P450 monooxygenase according to claim 1 , wherein glutamic acid at position 88 is substituted by alanine.

5. The modified P450 monooxygenase according to claim 4 , further comprising at least one of the following substitutions:

a) substitution of glutamic acid at position 199 by an amino acid selected from the group consisting of glutamine, isoleucine, leucine, phenylalanine, histidine, methionine, arginine, serine, threonine, tyrosine, tryptophan, alanine, valine, and lysine; and/or

b) substitution of glutamine at position 209 by alanine.

6. The modified P450 monooxygenase according to claim 1 , having an addition of up to 35 amino acids at the N-terminus and/or the C-terminus.

7. The modified P450 monooxygenase according to claim 1 , having a deletion of up to 35 amino acids at the N-terminus and/or the C-terminus.

8. The modified P450 monooxygenase according to claim 1 , leading to an increased activity on at least one hydrocarbon selected from the group consisting of naphthalene, 7-ethoxy-hydroxycoumarin, acenaphthene, florene, indene, methylbenzene, and ethylbenzene.

9. A nucleic acid sequence encoding any of the modified P450 monooxygenase according to claim 1 and its complementary nucleic acid sequence.

10. An expression construct, comprising the nucleic acid sequence of claim 9 under the genetic control of a regulatory nucleic acid sequence.

11. A vector, comprising the nucleic acid sequence of claim 9 .

12. A microorganism comprising the nucleic acid of claim 9 .

13. The microorganism according to claim 12 , wherein the microorganism is-belongs to the genus Rhodococcus or Escherichia.

14. A method for producing the modified p450 monooxygenase of claim 1 comprising: incubating a recombinant microorganism comprising a nucleic acid encoding the modified p450 monooxygenase under conditions suitable for the expression of the modified p450 monooxygenase.

15. A method for the hydroxylation of an aromatic hydrocarbon, comprising:

mixing at least one of the modified P450 monooxygenases according to claim 1 with said aromatic hydrocarbon under conditions to hydroxylate said aromatic hydrocarbon.

16. The method according to claim 15 , wherein the aromatic hydrocarbon is selected from the group consisting of naphthalene, 7-ethoxy-hydroxycoumarin, acenaphthene, florene, indene, methylbenzene, ethylbenzene, and mixtures thereof.

17. The method according to claim 15 , wherein the aromatic hydrocarbon is hydroxylated to form a hydroxylated aromatic hydrocarbon selected from the group consisting of 1-naphthol, 7-hydroxycoumarin, 1-acenaphthylene, 9-benflumetol, indenol, benzyl alcohol, 3-methylbenzyl alcohol, and mixtures thereof.

18. The modified p450 monooxygenase according to claim 1 , wherein the at least one amino acid is selected from the group consisting of glutamic acid 88, lysine 89, threonine 100, leucine 101, arginine 103, asparagine 199, arginine 203, proline 204, glutamine 209, and combinations thereof.

19. The microorganism of claim 12 , comprising an expression construct and/or a vector comprising the nucleic acid.

20. The method according to claim 15 , wherein mixing comprises combining a recombinant microorganism with the aromatic hydrocarbon, said recombinant microorganism comprising a nucleic acid encoding the modified p450 monooxygenase.

21. The modified P450 monooxygenase according to claim 2 , further comprising at least one amino acid selected from the group consisting of leucine 87, glutamic acid 88, lysine 89, isoleucine 90, threonine 91, proline 92, valine 93, serine 94, glutamic acid 96, threonine 98, threonine 100, leucine 101, arginine 103, tyrosine 104, aspartic acid 105, histidine 196, threonine 197, valine 198, asparagine 199, threonine 200, tryptophan 201, glycine 202, arginine 203, proline 204, proline 206, glutamic acid 207, glutamic acid 208, valine 210 and combinations thereof being substituted by alanine.

22. The modified P450 monooxygenase according to claim 1 , wherein at least one amino acid of SEQ ID NO.: 1 selected from the group consisting of leucine 87, glutamic acid 88, lysine 89, isoleucine 90, threonine 91, proline 92, valine 93, serine 94,threonine 98, threonine 100, leucine 101, arginine 103, tyrosine 104, aspartic acid 105, histidine 196, threonine 197, valine 198, asparagine 199, threonine 200, tryptophan 201, glycine 202, arginine 203, proline 204, proline 206, glutamic acid 207, glutamic acid 208, glutamine 209, and valine 210 is substituted by alanine.

Assignments (2)
MERGER Recorded Oct 29, 2024
From: COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
To: COVESTRO DEUTSCHLAND AG
Reel/Frame 069272/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2021
From: GUO, RUIJING; LIN, JEN-CHIEH; TAO, SHA; QIAN, YING; QIU, CHENGGANG; CHEN, KEQUAN; LI, KANG
To: COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG
Reel/Frame 057978/0363 →
Priority Claims (4)
WO PCT/CN2019/093275 · Jun 27, 2019 · international
WO PCT/CN2019/093326 · Jun 27, 2019 · international
EP 19192042 · Aug 16, 2019 · regional
EP 19192044 · Aug 16, 2019 · regional
Continuity (1)
Related Publication 20220220455A1 · Jul 14, 2022
References Cited (9)
Fowler. Cytochrome P450 Monooxygenase can be Redesigned to Catalyse the Regioselective Aromatic Hydroxylation of Diphenylmethane. J. Chem. Soc., Chem. Commun., 1994, pp. 2761-2762. [cited by examiner]
Fransceus. J Ind Microbiol Biotechnol. May 2017;44(4-5):687-695. [cited by examiner]
Sanavia. Computational and Structural Biotechnology Journal, vol. 18, 2020, pp. 1968-1979. [cited by examiner]
Studer. Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes. Biochem. J. (2013) 449, 581-594. [cited by examiner]
Unger. J. Biol. Chem. 261, 1158-1163, 1986. [cited by examiner]
Liu, L. et al, Cloning, expression, and characterization of a self-sufficient cytochrome P450 monooxygenase from Rhodococcus ruber DSM 44319, Applied Microbiology and Biotechnology, vol. 72, No. 5, Apr. 11, 2006, pp. 87… [cited by applicant]
Tao, S. et al., “Egineering substrate recognition sites of cytochrome P450 monooxygenase CYP116B3 from Rhodococcus ruber for enhanced regiospecific naphtalene hydroxylation”, Molecular Catalysis; vol. 493, pp. 1-6; Jul.… [cited by applicant]
Roberts, G.A. et al., Identification of a New Class of Cytochrome P450 from a [cited by applicant]
International Search Report, PCT/EP2020/066891, date of mailing: Oct. 8, 2020, Authorized officer: Ulrike Fuchs. [cited by applicant]